In summary, our work primarily unveils a clear alteration of the splicing machinery in lung carcinoids that is linked to three specific factors, NOVA1, PRPF8 and SRSF10, which are differentially associated to pathological features, distinct profiles of splicing events, and key functional actions. This evidence concerns the gene PRPF8 and lung carcinoid tumor.